Skip to main content

Advertisement

Table 3 Factors (non-measurable variables) which significantly influence NT-proBNP level.

From: Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study

Factors which significantly affect NT-proBNP after inclusion after 2 months
atorvastatin treatment - p = 0.01
renal insufficiency - p = 0.04
atrial fibrillation p = 0.03 -
digoxin therapy p = 0.001 p = 0.001
  1. ABBREVIATIONS: NT-proBNP - N-terminal pro-brain natriuretic peptide.